Letter: ciclosporin and vedolizumab for steroid‐refractory ulcerative colitis
暂无分享,去创建一个
[1] D. Banerjee,et al. Letter: does vitamin D have a potential role against COVID‐19? , 2020, Alimentary pharmacology & therapeutics.
[2] P. Davis,et al. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients , 2020, Pharmacological Research.
[3] L. Calò,et al. ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements , 2020, Journal of clinical medicine.
[4] A. Panarese,et al. Letter: Covid‐19, and vitamin D , 2020, Alimentary pharmacology & therapeutics.
[5] G. Karimi,et al. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) , 2020, Pharmacological Research.
[6] Yan Wang,et al. Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19 , 2020, Journal of medical virology.
[7] D. Rubin,et al. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis , 2019, Alimentary pharmacology & therapeutics.
[8] Minghui Zhu,et al. Vitamin D attenuates myocardial ischemia–reperfusion injury by inhibiting inflammation via suppressing the RhoA/ROCK/NF‐ĸB pathway , 2019, Biotechnology and applied biochemistry.
[9] Sergio Lavandero,et al. Counter-regulatory renin–angiotensin system in cardiovascular disease , 2019, Nature Reviews Cardiology.
[10] K. Farkas,et al. New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab. , 2018, Journal of Crohn's & colitis.
[11] P. Davis,et al. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism , 2014, Journal of hypertension.
[12] K. Farkas,et al. Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis: switching to infliximab is more effective than treating with concomitant immunomodulators. , 2011, Journal of clinical gastroenterology.
[13] A. D'Angelo,et al. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. , 2010, Journal of nephrology.